Reviews

Research progress on the effect and underlying mechanism of interleukin ⁃ 38 in central nervous system diseases#br#

Expand
  • Department of Forensic Medicine,School of Basic Medicine and Biological Sciences,Soochow University,Suzhou 215000,China

Online published: 2022-02-25

Abstract

Interleukin(IL)⁃38,a newly discovered anti⁃inflammatory cytokine in the IL⁃1 family,isexpressed in a variety of tissues and secreted by a variety of cells. By binding to multiple receptors such as IL⁃36R,IL⁃1RAPL1 and IL⁃1R1,IL⁃38 plays an essential role in the physiology and pathogenesis of the central nervoussystem(CNS). IL⁃38 mitigates pathological damage by inhibiting the expression of Th17 in neuromyelitisoptica.IL⁃38 improves the symptoms of stroke by inhibiting SIRT1/HIF⁃1α signaling pathway. However,the role of IL⁃38in neurological diseases and its potential mechanism need to be further studied. This review systematically and com⁃prehensively summarizes the biological characteristics,pathological effects and potential mechanisms of IL⁃38 un⁃der physiological and pathological conditions,aiming to explore potential molecular targets and new therapeuticstrategies for CNS diseases.

Cite this article

CAI Luwei, TAO Luyang, GAO Yuan. . Research progress on the effect and underlying mechanism of interleukin ⁃ 38 in central nervous system diseases#br#[J]. The Journal of Practical Medicine, 2022 , 38(4) : 511 -515 . DOI: 10.3969/j.issn.1006⁃5725.2022.04.023

Options
Outlines

/